Palomar (NASDAQ:PLMR) CEO Mac Armstrong Sells 5,000 Shares

Palomar Holdings, Inc. (NASDAQ:PLMRGet Free Report) CEO Mac Armstrong sold 5,000 shares of the firm’s stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $122.60, for a total value of $613,000.00. Following the sale, the chief executive officer directly owned 343,388 shares of the company’s stock, valued at $42,099,368.80. This represents a 1.44% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Mac Armstrong also recently made the following trade(s):

  • On Saturday, January 31st, Mac Armstrong sold 2,205 shares of Palomar stock. The stock was sold at an average price of $121.74, for a total transaction of $268,436.70.
  • On Saturday, January 31st, Mac Armstrong sold 2,205 shares of Palomar stock. The stock was sold at an average price of $121.74, for a total transaction of $268,436.70.
  • On Thursday, January 29th, Mac Armstrong sold 5,399 shares of Palomar stock. The shares were sold at an average price of $122.04, for a total transaction of $658,893.96.
  • On Thursday, January 29th, Mac Armstrong sold 5,399 shares of Palomar stock. The shares were sold at an average price of $122.04, for a total transaction of $658,893.96.
  • On Wednesday, January 28th, Mac Armstrong sold 11,484 shares of Palomar stock. The stock was sold at an average price of $119.88, for a total value of $1,376,701.92.
  • On Wednesday, January 21st, Mac Armstrong sold 5,000 shares of Palomar stock. The shares were sold at an average price of $129.00, for a total value of $645,000.00.
  • On Thursday, January 15th, Mac Armstrong sold 2,310 shares of Palomar stock. The stock was sold at an average price of $130.00, for a total value of $300,300.00.
  • On Friday, November 21st, Mac Armstrong sold 5,000 shares of Palomar stock. The shares were sold at an average price of $122.86, for a total value of $614,300.00.

Palomar Price Performance

NASDAQ PLMR traded up $5.09 on Friday, reaching $132.10. The stock had a trading volume of 455,917 shares, compared to its average volume of 258,007. The company has a market cap of $3.50 billion, a P/E ratio of 18.40 and a beta of 0.44. The firm has a fifty day moving average of $128.42 and a two-hundred day moving average of $123.23. Palomar Holdings, Inc. has a 1-year low of $107.75 and a 1-year high of $175.85.

Palomar (NASDAQ:PLMRGet Free Report) last announced its earnings results on Wednesday, February 11th. The company reported $2.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.06 by $0.18. Palomar had a net margin of 22.50% and a return on equity of 23.48%. The company had revenue of $492.63 million during the quarter, compared to analysts’ expectations of $204.58 million. During the same quarter in the previous year, the business posted $1.52 earnings per share. Palomar’s quarterly revenue was up 62.7% on a year-over-year basis. Research analysts predict that Palomar Holdings, Inc. will post 5.99 EPS for the current fiscal year.

Analyst Ratings Changes

PLMR has been the subject of several recent research reports. Weiss Ratings upgraded Palomar from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, January 14th. Wall Street Zen downgraded Palomar from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Evercore ISI assumed coverage on shares of Palomar in a research report on Monday. They set an “outperform” rating and a $150.00 price objective for the company. Keefe, Bruyette & Woods increased their price objective on shares of Palomar from $170.00 to $171.00 and gave the stock an “outperform” rating in a research note on Tuesday, January 6th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Palomar from $145.00 to $155.00 and gave the company an “overweight” rating in a research report on Wednesday, January 7th. Seven analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, Palomar has an average rating of “Moderate Buy” and a consensus target price of $158.14.

Read Our Latest Analysis on Palomar

Key Stories Impacting Palomar

Here are the key news stories impacting Palomar this week:

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of PLMR. Allworth Financial LP raised its stake in Palomar by 1,970.0% during the second quarter. Allworth Financial LP now owns 207 shares of the company’s stock worth $32,000 after acquiring an additional 197 shares in the last quarter. Salomon & Ludwin LLC acquired a new position in Palomar during the 3rd quarter worth approximately $25,000. Richardson Financial Services Inc. lifted its stake in Palomar by 210.0% in the 3rd quarter. Richardson Financial Services Inc. now owns 217 shares of the company’s stock valued at $25,000 after purchasing an additional 147 shares during the last quarter. Geneos Wealth Management Inc. acquired a new stake in Palomar in the fourth quarter valued at approximately $32,000. Finally, Hollencrest Capital Management grew its stake in shares of Palomar by 56.5% during the second quarter. Hollencrest Capital Management now owns 313 shares of the company’s stock worth $48,000 after buying an additional 113 shares during the last quarter. Institutional investors own 90.25% of the company’s stock.

About Palomar

(Get Free Report)

Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.

In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.

Read More

Insider Buying and Selling by Quarter for Palomar (NASDAQ:PLMR)

Receive News & Ratings for Palomar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palomar and related companies with MarketBeat.com's FREE daily email newsletter.